This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Mehta, R. M. Articles by Niederman, M. S. Search for Related Content PubMed PubMed Citation Articles by Mehta, R. M. Articles by Niederman, M. S. Social Bookmarking                         What's this?

Nosocomial Pneumonia in the Intensive Care Unit: Controversies and Dilemmas

Division of Pulmonary/Critical Care, Brooklyn VA Medical Center, State University of New York, Brooklyn

Michael S. Niederman, MD, FCCP

Winthrop University Hospital and State University of New York at Stony Brook. mniederman{at}winthrop.org

Nosocomial pneumonia (NP), and its most serious form, ventilator-associated pneumonia (VAP), is a major cause of morbidity and mortality in the ICU. Numerous controversies exist, from diagnostic criteria to prevention and treatment, including the issues of attributable mortality of VAP, differences in the approach to early and late VAP, and the best diagnostic methods. Initial, accurate therapy is one of the most important factors determining outcome in VAP. Antibiotic monotherapy versus combination therapy is not clearly defined, as clinicians struggle with the dual risk of inadequate therapy negatively affecting outcome and overtreatment promoting antibiotic resistance. The role of airway and gastrointestinal colonization and innovative preventive strategies such as noninvasive ventilation, antibiotic rotation, and aerosolized antibiotics are discussed. No uniform standards exist for the approach to VAP. The authors highlight the major controversies and dilemmas in the clinical approach to VAP, with recommendations for the bedside management of these patients.

Key Words: nosocomial pneumonia • prevention of pneumonia • antibiotic therapy • antibiotic resistance • pneumonia pathogenesis

Journal of Intensive Care Medicine, Vol. 18, No. 4, 175-188 (2003)
DOI: 10.1177/0885066603254249


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				P. J. O'Brien, J. A. Joss, S. L. Crofts, F. Bloos, and G. Marx Application of a ventilator care bundle and outcome Br. J. Anaesth., January 1, 2010; 104(1): 112 - 113. [Full Text] [PDF]

				K. Yang, H. Zhuo, B J. Guglielmo, and J. Wiener-Kronish Multidrug-Resistant Pseudomonas aeruginosa Ventilator-Associated Pneumonia: The Role of Endotracheal Aspirate Surveillance Cultures Ann. Pharmacother., January 1, 2009; 43(1): 28 - 35. [Abstract] [Full Text] [PDF]

				A. Reinhardt, T. Kohler, P. Wood, P. Rohner, J.-L. Dumas, B. Ricou, and C. van Delden Development and Persistence of Antimicrobial Resistance in Pseudomonas aeruginosa: a Longitudinal Observation in Mechanically Ventilated Patients Antimicrob. Agents Chemother., April 1, 2007; 51(4): 1341 - 1350. [Abstract] [Full Text] [PDF]